Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

NCT06975917 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT06975917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06975917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)
Lead sponsor
Ankara University
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2024
Completion date
May 30, 2025
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer, biliary tract cancers (btc)